Investors and Media

SEC Filing Details

Document Details

Form
Filing Date
Nov 25, 2024
Document Date
Nov 13, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
4D Molecular Therapeutics
Issuer
4D MOLECULAR THERAPEUTICS, INC.
Filer
RA CAPITAL MANAGEMENT, L.P.